HCC Virtual Peer Roundtable Discussion
February 8 @ 5:30 pm EST
Hepatocellular Carcinoma has seen an incredible amount of advances in the last 5-years. The treatment landscape has shifted so much and with so many therapy options. Experts in HCC break down the data, the guidelines, and even provide opinions on proper sequencing of agents…all in a non-promotional, unbiased manner.
Must be a practicing healthcare provider in oncology to attend.